Leuprolide Acetate USP For Compounding (API) ** Refrigerated**

Leuprolide Acetate USP For Compounding (API) is a synthetic peptide utilized in the treatment of hormone-dependent conditions, such as prostate cancer, endometriosis, and uterine fibroids. By acting as a potent gonadotropin-releasing hormone (GnRH) agonist, it effectively reduces the production of certain hormones like testosterone and estrogen, thus shrinking tumors and alleviating symptoms associated with these conditions. This active pharmaceutical ingredient is a critical component for personalized therapeutic regimens, allowing healthcare professionals to tailor treatments that manage hormone levels and improve patient outcomes. Adhering to high-quality standards, Leuprolide Acetate supports advancements in oncology, reproductive health, and endocrine therapy.

Leuprolide Acetate USP is a synthetic peptide analog of naturally occurring gonadotropin releasing hormone (GnRH). It is used as an active pharmaceutical ingredient in medications for hormonal therapy for various conditions such as prostate cancer, endometriosis, and uterine fibroids. Leuprolide Acetate USP works by blocking the production of certain hormones, thereby reducing their levels in the body and helping to manage the symptoms of these conditions.

Leuprolide acetate USP for compounding is used to treat hormone-related conditions, such as endometriosis, uterine fibroids, and prostate cancer. It works by suppressing the production of certain hormones in the body that can cause these conditions to worsen or develop. This medication may be used in the form of an injection or implant, and it is typically prescribed by a healthcare provider for individualized treatment plans. Compounding allows for the medication to be tailored to the specific needs of the patient, as it can be formulated in different strengths, dosage forms, and combination therapies.

CAS Number:  74381-53-6

Properties: Light Sensitive | Hygroscopic | Refrigerated